Chemical Company with specialization in Fine chemicals, Speciality chemicals, and Performance Chemicals which cater to several industries like water treatment, fertilizers, and pharmaceuticals is in focus after reporting its Q3 Results.
Stock Price Movement
With a market capitalization of Rs. 970 Crore, the stock of Indo Amines opened at Rs. 138.05 up 1.20 percent from yesterday’s close, but later fell to a low of 130 and made a sharp recovery of over 7% from the bottom. Additionally, the 1 month’s return for the stock is -7 percent, and the past 5-year return is 21 percent.
Q3FY25 Results
The company reported a 33.45 percent YoY increase in revenue from operations from Rs.193.95 Crore in Q3FY24 to Rs. 258.84 Crore in Q3FY25. On a QoQ basis, the company reported a decrease of 3.90 percent in revenue from operations from Rs. 269.35 Crore in the previous quarter.
Their Net profit saw a 15.17 percent YoY increase from Rs. 9.82 Crore to Rs. 11.31 Crore for the same period. On a QoQ, basis their net profits also saw a decrease of 17.80 percent from Rs. 13.76 Crore for the same period.
The Debt to Equity ratio is 0.85 for Q3FY25 compared to 0.90 for Q3FY24, the Debt to Asset ratio is 0.36 compared to 0.37 for the same period, and the PE ratio stands at 18.61 compared to the industry PE of 53.28.
About the Company
Indo Amines Limited is an Indian chemical manufacturing company specializing in fine, specialty, and performance chemicals. Established in 1994, the company operates multiple manufacturing facilities across India, supplying products to industries such as pharmaceuticals, agrochemicals, petrochemicals, road construction, and perfumery. Their extensive product portfolio includes aliphatic and aromatic amines, fatty acids, amides, emulsifiers, and corrosion inhibitors, among others.
Written By Abhishek Das
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
